![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Teva to Acquire Cephalon in $6.8 Billion Transaction
Teva Pharmaceutical Industries Ltd. and Cephalon, Inc.announced that their Boards of Directors have unanimously approved...
Ranbaxy Launches Generic Olanzapine Tablets in Spain
Ranbaxy Laboratories Limited announced the Day-1 launch of Olanzapine Tablets, the generic version of Zyprexa....
SGS Korea Lab becomes a Certified Body Technical Lab for Medical Devices
IEC System for Conformity Testing and Certification of Electrotechnical Equipment and Components CB Scheme and...
Aurobindo Pharma receives final approval for Divalproex Sodium Delayed-Release Tablets
Aurobindo Pharma Limited is pleased to announce that the company has received final approval from...
Thermo Fisher Scientific Introduces New Cell Assay for Predictive Liver Toxicity Testing
Thermo Fisher Scientific Inc., the world leader in serving science has introduced the ToxInsight DILI...
Novartis completes merger with Alcon
Novartis announced that it completed the merger of Alcon, Inc. into Novartis. The completion...
NextPharma Announces the Addition of a New Encapsulation/Over-encapsulation Machine
NextPharma the leading European provider of product development, contract manufacturing and cold chain and...
Thermo Fisher Scientific Completes Sales of Athena Diagnostics and Lancaster Laboratories
Thermo Fisher Scientific Inc., the world leader in serving science, has completed the previously...
Nycomed announces REACT study to evaluate impact of Daxas
Nycomed announced plans for an international phase III/IV study investigating the effect of Daxas® (500μg...
APP Pharmaceuticals issues nationwide voluntary recall of Irinotecan Hydrochloride Injection
APP Pharmaceuticals, Inc., announced that it has issued a voluntary recall of five lots of...